1. Home
  2. COCP vs KXIN Comparison

COCP vs KXIN Comparison

Compare COCP & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • KXIN
  • Stock Information
  • Founded
  • COCP 2006
  • KXIN 2015
  • Country
  • COCP United States
  • KXIN China
  • Employees
  • COCP N/A
  • KXIN N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • KXIN Retail-Auto Dealers and Gas Stations
  • Sector
  • COCP Health Care
  • KXIN Consumer Discretionary
  • Exchange
  • COCP Nasdaq
  • KXIN Nasdaq
  • Market Cap
  • COCP 15.3M
  • KXIN 13.0M
  • IPO Year
  • COCP N/A
  • KXIN N/A
  • Fundamental
  • Price
  • COCP $1.60
  • KXIN $0.92
  • Analyst Decision
  • COCP Strong Buy
  • KXIN
  • Analyst Count
  • COCP 1
  • KXIN 0
  • Target Price
  • COCP $7.00
  • KXIN N/A
  • AVG Volume (30 Days)
  • COCP 17.1K
  • KXIN 88.8K
  • Earning Date
  • COCP 05-12-2025
  • KXIN 01-01-0001
  • Dividend Yield
  • COCP N/A
  • KXIN N/A
  • EPS Growth
  • COCP N/A
  • KXIN N/A
  • EPS
  • COCP N/A
  • KXIN N/A
  • Revenue
  • COCP N/A
  • KXIN N/A
  • Revenue This Year
  • COCP N/A
  • KXIN N/A
  • Revenue Next Year
  • COCP N/A
  • KXIN N/A
  • P/E Ratio
  • COCP N/A
  • KXIN N/A
  • Revenue Growth
  • COCP N/A
  • KXIN N/A
  • 52 Week Low
  • COCP $1.12
  • KXIN $0.64
  • 52 Week High
  • COCP $3.26
  • KXIN $29.52
  • Technical
  • Relative Strength Index (RSI)
  • COCP 57.48
  • KXIN 44.49
  • Support Level
  • COCP $1.49
  • KXIN $0.86
  • Resistance Level
  • COCP $1.74
  • KXIN $0.94
  • Average True Range (ATR)
  • COCP 0.15
  • KXIN 0.09
  • MACD
  • COCP 0.04
  • KXIN -0.00
  • Stochastic Oscillator
  • COCP 63.79
  • KXIN 16.21

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

Share on Social Networks: